MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
The two murine double minute (MDM) family members MDM2 and MDMX are at the center
of an intense clinical assessment as molecular target for the management of cancer. Indeed …
of an intense clinical assessment as molecular target for the management of cancer. Indeed …
Waldenström macroglobulinaemia
R Fonseca, S Hayman - British journal of haematology, 2007 - Wiley Online Library
Over time, Waldenström macroglobulinaemia (WM) has evolved conceptually from a clinical
syndrome to a distinct clinicopathological entity. Progress is being made in standardization …
syndrome to a distinct clinicopathological entity. Progress is being made in standardization …
[HTML][HTML] Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia
F Nguyen-Khac, J Lambert, E Chapiro, A Grelier… - …, 2013 - ncbi.nlm.nih.gov
Waldenström's macroglobulinemia is a disease of mature B cells, the genetic basis of which
is poorly understood. Few recurrent chromosomal abnormalities have been reported, and …
is poorly understood. Few recurrent chromosomal abnormalities have been reported, and …
TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia
S Poulain, C Roumier, E Bertrand, A Renneville… - Clinical Cancer …, 2017 - AACR
Purpose: TP53 is a tumor-suppressor gene that functions as a regulator influencing cellular
responses to DNA damage, and TP53 alterations are associated with pejorative outcome in …
responses to DNA damage, and TP53 alterations are associated with pejorative outcome in …
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma
Waldenström macroglobulinemia (WM) is a B-cell malignancy characterized by the ability
of the B-cell clone to differentiate into plasma cells. Although the clinical syndrome and the …
of the B-cell clone to differentiate into plasma cells. Although the clinical syndrome and the …
Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management
MA Gertz - American journal of hematology, 2019 - Wiley Online Library
Disease Overview Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis
EM Ocio, RFJ Schop, B Gonzalez… - British journal of …, 2007 - Wiley Online Library
Fluorescence in situ hybridisation (FISH) is an effective technique for the cytogenetic
analysis of Waldenström macroglobulinemia (WM), but the potential impact of molecular …
analysis of Waldenström macroglobulinemia (WM), but the potential impact of molecular …
Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management
MA Gertz - American journal of hematology, 2017 - Wiley Online Library
Disease Overview: Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management.
MA Gertz - American journal of hematology, 2015 - europepmc.org
Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and
management. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …
management. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …
Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management
MA Gertz - American journal of hematology, 2012 - pubmed.ncbi.nlm.nih.gov
Disease overview Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …